AFT blames covid for up to 50% profit downgrade

Staff reporters
Thu, 01 Apr 2021

AFT Pharmaceuticals has downgraded its profit guidance by as much as 50% and blames that on delays to licensing negotiations, hampered by the covid pandemic.The company now expects operating profit will come in between $9 million and $11m for the year ended yesterday compared with its November guidance of $14m to $18m."We are disappointed to be revising our guidance, a move which, to a large extent, reflects delays to licensing negotiations we expected to conclude in the 2021 financial year," said founder and managing director Hartley...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets FREE
Eroad shares fall to all-time low
Ella Somers | Thu, 30 Jun 2022

Fleet management company Eroad dropped 3.4% to $1.42 today – its lowest share price since 2016.

Finance
Finlay steps down as NZ Post chair as he joins RBNZ board
Jenny Ruth | Thu, 30 Jun 2022

No mention was made of Rodger Finlay's term ending as chair of NZ Post when controversy over his appointment to RBNZ's new board blew up earlier this month.

Opinion
My bet? Ardern says the EU-NZ FTA needs more work
Rebecca Howard | Thu, 30 Jun 2022

Arden’ll just say it’s very close, but more talks are needed. That’s much easier to spin than a deal at any cost.

Sponsored
Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges

Sponsored
Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.